基于冠状动脉腔内心电图评价速效救心丸对急性STEMI气滞血瘀证心肌损伤的影响

Evaluation of the Effect of Suxiao Jiuxin Pills on Myocardial Damage in Acute STEMI with Qi Stagnation and Blood Stasis Based on Intracoronary Electrocardiogram

  • 摘要: 目的  基于冠状动脉腔内心电图评价速效救心丸对急性ST段抬高型心肌梗死(ST-segment elevation myocardial infarction, STEMI)气滞血瘀证心肌损伤的影响。方法  选择2019年3月至2020年2月于南京中医药大学附属中西医结合医院行经皮冠状动脉介入治疗(Percutaneous coronary intervention, PCI)术的急性STEMI气滞血瘀证60例, 采用随机数字表法分为对照组和研究组各30例。2组均给予术前标准治疗, 研究组术前加予速效救心丸含服。观察PCI术前及术后1周2组患者中医证候积分变化、临床疗效, 以及术后冠状动脉罪犯血管腔内心电图ST段回落值(ΔIST)和心肌梗死溶栓治疗(Thrombolysis myocardial infarction, TIMI)血流。结果  治疗后, 研究组中医临床疗效和ΔIST显著高于对照组(P < 0.05);2组各项中医证候积分均显著下降(P < 0.01), 且研究组胸闷、胸胁胀满、自汗证候积分显著低于对照组(P < 0.05)。2组患者术后TIMI血流分级以及不良反应无统计学差异(P>0.05)。结论  术前给予速效救心丸可进一步减少急性STEMI气滞血瘀证患者的心肌损伤, 改善临床症状, 提高中医临床疗效, 且不增加不良反应。

     

    Abstract: OBJECTIVE  To evaluate the effect of Suxiao Jiuxin pills on myocardial damage in acute ST-segment elevation myocardial infarction (STEMI) with qi stagnation and blood stasis based on intracoronary electrocardiogram.METHODS  60 acute STEMI patients with qi stagnation and blood stasis who underwent percutaneous coronary intervention (PCI) directly from March 2019 to February 2020 at Integrated Chinese and Western Medicine Hospital Affiliated to Nanjing University of Chinese Medicine were selected. Besides, according to the random number table, these patients were divided into the control group and the study group, with 30 cases in each group. The two groups were given standard preoperative treatment, while based on that, the study group was given sublingual administration of Suxiao Jiuxin pills. The clinical efficacy of traditional Chinese medicine (TCM), as well as TCM syndrome score and adverse reactions were compared between the two groups after one week of treatment. In addition, the value of ST-segment resolution (ΔIST) of intracoronary electrocardiogram combined with the blood flow of thrombolysis and thrombin inhibition in myocardial infarction (TIMI) were compared after PCI.RESULTS  The TCM clinical efficacy and ΔIST in the study group were significantly higher than those in the control group (P < 0.05), while the TCM syndrome scores of both groups were decreased significantly (P < 0.01). In addition, the syndrome scores of chest distress, distention and fullness in the chest and hypochondriac region, as well as spontaneous sweating in the study group were significantly lower than those in the control group (P < 0.05). However, there was no statistical difference in the postoperative TIMI flow grades and adverse reactions between the two groups (P>0.05).CONCLUSION  Preoperative administration of Suxiao Jiuxin pills can further reduce myocardial damage, alleviate clinical symptoms, and enhance the TCM clinical efficacy without increasing adverse reactions in patients with acute STEMI with qi stagnation and blood stasis.

     

/

返回文章
返回